554 related articles for article (PubMed ID: 10403641)
1. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.
Cohen GB; Gandhi RT; Davis DM; Mandelboim O; Chen BK; Strominger JL; Baltimore D
Immunity; 1999 Jun; 10(6):661-71. PubMed ID: 10403641
[TBL] [Abstract][Full Text] [Related]
2. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.
Pizzato N; Derrien M; Lenfant F
Hum Immunol; 2004 Nov; 65(11):1389-96. PubMed ID: 15556689
[TBL] [Abstract][Full Text] [Related]
3. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.
Bonaparte MI; Barker E
Blood; 2004 Oct; 104(7):2087-94. PubMed ID: 15117765
[TBL] [Abstract][Full Text] [Related]
4. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
[TBL] [Abstract][Full Text] [Related]
5. HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts.
Ward JP; Bonaparte MI; Barker E
AIDS; 2004 Sep; 18(13):1769-79. PubMed ID: 15316337
[TBL] [Abstract][Full Text] [Related]
6. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
Matusali G; Potestà M; Santoni A; Cerboni C; Doria M
J Virol; 2012 Apr; 86(8):4496-504. PubMed ID: 22301152
[TBL] [Abstract][Full Text] [Related]
7. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.
Williams M; Roeth JF; Kasper MR; Fleis RI; Przybycin CG; Collins KL
J Virol; 2002 Dec; 76(23):12173-84. PubMed ID: 12414957
[TBL] [Abstract][Full Text] [Related]
8. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
[TBL] [Abstract][Full Text] [Related]
9. HIV's evasion of the cellular immune response.
Collins KL; Baltimore D
Immunol Rev; 1999 Apr; 168():65-74. PubMed ID: 10399065
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity.
Cerboni C; Neri F; Casartelli N; Zingoni A; Cosman D; Rossi P; Santoni A; Doria M
J Gen Virol; 2007 Jan; 88(Pt 1):242-250. PubMed ID: 17170457
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
12. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells.
Pazmany L; Mandelboim O; Valés-Gómez M; Davis DM; Reyburn HT; Strominger JL
Science; 1996 Nov; 274(5288):792-5. PubMed ID: 8864122
[TBL] [Abstract][Full Text] [Related]
13. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
[TBL] [Abstract][Full Text] [Related]
14. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
[TBL] [Abstract][Full Text] [Related]
15. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
[TBL] [Abstract][Full Text] [Related]
16. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
Tomiyama H; Akari H; Adachi A; Takiguchi M
J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
18. Species-specific effects of HIV-1 Nef-mediated MHC-I downmodulation.
Fleis R; Filzen T; Collins KL
Virology; 2002 Nov; 303(1):120-9. PubMed ID: 12482663
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis.
Maziarz RT; Mentzer SJ; Burakoff SJ; Faller DV
Cell Immunol; 1990 Oct; 130(2):329-38. PubMed ID: 2119892
[TBL] [Abstract][Full Text] [Related]
20. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I.
Ashrafi GH; Haghshenas MR; Marchetti B; O'Brien PM; Campo MS
Int J Cancer; 2005 Jan; 113(2):276-83. PubMed ID: 15386416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
